Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-21

Clinical Trial Update: Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure [NA]

View source ↗

Summary

A clinical trial evaluating adipose-derived stem cells for non-ischemic congestive heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Non-Ischemic Congestive Heart Failure | NA | Status: WITHDRAWN